Literature DB >> 9617396

Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis.

H Alfredson1, T Pietilä, P Jonsson, R Lorentzon.   

Abstract

We prospectively studied the effect of heavy-load eccentric calf muscle training in 15 recreational athletes (12 men and 3 women; mean age, 44.3 +/- 7.0 years) who had the diagnosis of chronic Achilles tendinosis (degenerative changes) with a long duration of symptoms despite conventional nonsurgical treatment. Calf muscle strength and the amount of pain during activity (recorded on a visual analog scale) were measured before onset of training and after 12 weeks of eccentric training. At week 0, all patients had Achilles tendon pain not allowing running activity, and there was significantly lower eccentric and concentric calf muscle strength on the injured compared with the noninjured side. After the 12-week training period, all 15 patients were back at their preinjury levels with full running activity. There was a significant decrease in pain during activity, and the calf muscle strength on the injured side had increased significantly and did not differ significantly from that of the noninjured side. A comparison group of 15 recreational athletes with the same diagnosis and a long duration of symptoms had been treated conventionally, i.e., rest, nonsteroidal antiinflammatory drugs, changes of shoes or orthoses, physical therapy, and in all cases also with ordinary training programs. In no case was the conventional treatment successful, and all patients were ultimately treated surgically. Our treatment model with heavy-load eccentric calf muscle training has a very good short-term effect on athletes in their early forties.

Entities:  

Mesh:

Year:  1998        PMID: 9617396     DOI: 10.1177/03635465980260030301

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  212 in total

1.  A randomised clinical trial of the efficacy of drop squats or leg extension/leg curl exercises to treat clinically diagnosed jumper's knee in athletes: pilot study.

Authors:  L J Cannell; J E Taunton; D B Clement; C Smith; K M Khan
Journal:  Br J Sports Med       Date:  2001-02       Impact factor: 13.800

2.  Where is the pain coming from in tendinopathy? It may be biochemical, not only structural, in origin.

Authors:  K M Khan; J L Cook; N Maffulli; P Kannus
Journal:  Br J Sports Med       Date:  2000-04       Impact factor: 13.800

3.  VO2 slow component and performance in endurance sports.

Authors:  V L Billat
Journal:  Br J Sports Med       Date:  2000-04       Impact factor: 13.800

Review 4.  Treatment of midportion Achilles tendinopathy: an evidence-based overview.

Authors:  Ruben Zwiers; Johannes I Wiegerinck; C Niek van Dijk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-11-01       Impact factor: 4.342

5.  Tendon injury and repair after core biopsies in chronic Achilles tendinosis evaluated by serial magnetic resonance imaging.

Authors:  A Shalabi; L Svensson; M Kristoffersen-Wiberg; P Aspelin; T Movin
Journal:  Br J Sports Med       Date:  2004-10       Impact factor: 13.800

6.  [Conservative treatment of Achilles tendinopathy].

Authors:  K Knobloch; T Hüfner
Journal:  Unfallchirurg       Date:  2010-09       Impact factor: 1.000

7.  Classification of Prevention in Sports Medicine and Epidemiology.

Authors:  Jenny Jacobsson; Toomas Timpka
Journal:  Sports Med       Date:  2015-11       Impact factor: 11.136

8.  CURRENT CONCEPTS IN PERIODIZATION OF STRENGTH AND CONDITIONING FOR THE SPORTS PHYSICAL THERAPIST.

Authors:  Daniel Lorenz; Scot Morrison
Journal:  Int J Sports Phys Ther       Date:  2015-11

Review 9.  Nonsurgical Treatment Options for Insertional Achilles Tendinopathy.

Authors:  Connor P Dilger; Ruth L Chimenti
Journal:  Foot Ankle Clin       Date:  2019-05-22       Impact factor: 1.653

10.  A DELPHI STUDY OF RISK FACTORS FOR ACHILLES TENDINOPATHY- OPINIONS OF WORLD TENDON EXPERTS.

Authors:  Seth O'Neill; Paul J Watson; Simon Barry
Journal:  Int J Sports Phys Ther       Date:  2016-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.